Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 104

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 104
---
 PARTICULAR INVESTOR. EACH PROSPECTIVE INVESTOR IN OUR SECURITIES IS URGED TO CONSULT ITS OWN TAX ADVISER ABOUT THE TAX CONSEQUENCES TO IT OF OWNING AND DISPOSING OF OUR SECURITIES IN LIGHT OF SUCH PROSPECTIVE INVESTOR’S OWN CIRCUMSTANCES.

| 69 |

<div align='center'>SELLING SHAREHOLDERS</div>

This prospectus covers the possible resale
from time to time by the selling shareholders identified in the table below of Ordinary Shares represented by Depositary Shares, including
Ordinary Shares represented by Depositary Shares issuable upon the exercise of the Series J Warrants, Series K Warrants, and the July
2024 Placement Agent Warrants (referred to in this section collectively and individually as the “warrants”). The selling shareholders
may sell some, all or none of their Ordinary Shares represented by Depositary Shares. We do not know how long the selling shareholders
will hold the warrants, whether any will exercise the warrants, and upon such exercise, how long such selling shareholders will hold the
Ordinary Shares represented by Depositary Shares before selling them, and we currently have no agreements, arrangements or understandings
with the selling shareholders regarding the sale of any of the shares.

The table below lists the selling shareholders
and other information regarding the beneficial ownership of the Ordinary Shares represented by Depositary Shares by each of the selling
shareholders. The second column lists the number of Ordinary Shares represented by Depositary Shares beneficially owned by each selling
shareholder, based on its ownership of Depositary Shares and warrants to purchase Depositary Shares, as of April 1, 2025 assuming exercise
of the warrants held by the selling shareholders on that date, without regard to any limitations on conversions or exercises. The third
column lists the maximum number of Ordinary Shares represented by Depositary Shares being offered in this prospectus by the selling shareholders.
The fourth and fifth columns list the amount of Ordinary Shares represented by Depositary Shares owned after the offering, by number of
Ordinary Shares represented by Depositary Shares and percentage of outstanding Ordinary Shares, assuming in both cases the sale of all
of the Ordinary Shares represented by Depositary Shares offered by the selling shareholders pursuant to this prospectus, and without regard
to any limitations on conversions or exercises.

In accordance with the terms of a registration
rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number